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Type 1 diabetes is thought to occur as a result of the loss of insulin-producing pancreatic b cells by an
environmentally triggered autoimmune reaction. In rodent models of diabetes, streptozotocin (STZ), a geno-
toxic methylating agent that is targeted to the b cells, is used to trigger the initial cell death. High single doses
of STZ cause extensive b-cell necrosis, while multiple low doses induce limited apoptosis, which elicits an
autoimmune reaction that eliminates the remaining cells. We now show that in mice lacking the DNA repair
enzyme alkylpurine-DNA-N-glycosylase (APNG), b-cell necrosis was markedly attenuated after a single dose of
STZ. This is most probably due to the reduction in the frequency of base excision repair-induced strand breaks
and the consequent activation of poly(ADP-ribose) polymerase (PARP), which results in catastrophic ATP
depletion and cell necrosis. Indeed, PARP activity was not induced in APNG2/2 islet cells following treatment
with STZ in vitro. However, 48 h after STZ treatment, there was a peak of apoptosis in the b cells of APNG2/2
mice. Apoptosis was not observed in PARP-inhibited APNG1/1 mice, suggesting that apoptotic pathways are
activated in the absence of significant numbers of DNA strand breaks. Interestingly, STZ-treated APNG2/2
mice succumbed to diabetes 8 months after treatment, in contrast to previous work with PARP inhibitors,
where a high incidence of b-cell tumors was observed. In the multiple-low-dose model, STZ induced diabetes
in both APNG2/2 and APNG1/1 mice; however, the initial peak of apoptosis was 2.5-fold greater in the
APNG2/2 mice. We conclude that APNG substrates are diabetogenic but by different mechanisms according
to the status of APNG activity.
Type 1 diabetes occurs in a genetically susceptible human
population as a result of the loss of the insulin-producing
pancreatic b cells. The disease is thought to be triggered by an
environmental agent(s) that initiates processes leading to an
eventual b-cell-destructive autoimmune response (6, 12, 14).
In animal models of the disease, the first observable abnor-
mality is an initial low level of b-cell death (27, 28) that primes
antigen-presenting cells such as dendritic cells and macro-
phages (19). This leads to the proliferation of autoreactive
lymphocytes and the ensuing selective elimination of the re-
maining b cells.
Much of what is known about the cellular mechanisms lead-
ing to type 1 diabetes has come from the study of both the
nonobese diabetic (NOD) mouse and the use of the methylat-
ing agent streptozotocin [2-deoxy-2-(3-methyl-3-nitrosourea)-
1-D-glucopyranose] (STZ) as the environmental trigger for the
disease. STZ is actively transported into pancreatic b cells via
the Glut-2 glucose transporter. It reacts at many sites in DNA
but in particular at the ring nitrogen and exocyclic oxygen
atoms of the DNA bases, predominantly producing 7-methyl-
guanine, 3-methyladenine (3-meA), and O6-methylguanine ad-
ducts (1, 37). 3-meA and 7-methylguanine are removed by the
action of alkylpurine-DNA-N-glycosylase (APNG) (also re-
ferred to as 3-methyladenine DNA glycosylase), leaving an
apurinic/apyrimidinic (AP) site that is acted upon by an AP
endonuclease. The resulting DNA strand breaks activate poly-
(ADP-ribose) polymerase (PARP), which synthesizes poly-
mers of ADP-ribose from NAD1, modifying acceptor proteins
at the site of DNA damage (38). PARP is thus part of a protein
complex that includes XRCC1, DNA polymerase b, and DNA
ligase III and is required for the efficient resynthesis and liga-
tion steps of base excision repair (5).
Therefore, a single high dose of STZ will produce a large
number of DNA strand breaks, leading to the overactivation of
PARP. This results in a catastrophic fall in cellular NAD1
levels and thus to nonphysiological concentrations of ATP,
loss of membrane integrity, and necrotic b-cell death (30). In
agreement with this, mice deficient in PARP or treated with
PARP inhibitors are protected from STZ-induced b-cell ne-
crosis and do not develop hyperglycemia (2, 25, 33). However,
although the initial destruction of the b cells can be avoided by
the use of PARP inhibitors, the resulting long-term biological
consequence of this is the development of a high incidence of
pancreatic b-cell tumors (36, 40). Conversely, a regimen of five
daily subdiabetogenic doses of STZ (the multiple-low-dose
STZ model, MLDS) induces a peak of apoptotic b-cell death
after 5 days of STZ treatment (27), while a second peak of
apoptosis is seen at 11 days, when lymphocytic infiltration of
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the islet occurs. The preimmune stage of b-cell apoptosis has
also been reported to occur in the NOD mouse model (28).
However, the molecular mechanisms leading to the initial peak
of STZ-induced b-cell apoptosis in the MLDS model are un-
clear, and it is also unknown whether the initial induction of
b-cell apoptosis is important in triggering the resulting auto-
immune reaction.
Thus, while the role of PARP in STZ-induced b-cell death
has been studied extensively, we were interested in determin-
ing the role of APNG in modulating both the cytotoxic effects
of a single high dose of STZ and its effect in the MLDS model
of diabetes. Using a recently described APNG-deficient mouse
strain (8), our results showed that although APNG2/2 mice
were substantially resistant to single, high-dose STZ-induced
b-cell necrosis and the initial onset of diabetes, a smaller peak
of b-cell apoptosis was observed 48 h after treatment. How-
ever, analogous to the onset of autoimmune diabetes in the
NOD mouse model but in contrast to that reported for PARP-
inhibited animals, the STZ-treated APNG2/2 mice eventually
succumbed to diabetes after several months due to a marked
autoimmune reaction. Additionally, in the MLDS model of
diabetes, the APNG2/2 mice also exhibited an initial increased
sensitivity to b-cell apoptosis.
MATERIALS AND METHODS
Mice. APNG2/2 mice were generated as previously described (8). They
were backcrossed onto a C57BL/6J background for nine generations, and the
APNG1/2 mice thus generated were crossed to yield the male mice used in these
experiments. All animal experiments were carried out under the Animals (Sci-
entific Procedures) Act 1986, in the United Kingdom.
Animal dosing. STZ (Sigma) was dissolved in sodium citrate buffer (pH 4.5)
and injected intraperitoneally, either as a single high dose of 140 mg/kg or, for
the MLDS experiments, as five daily doses of 40 mg/kg. In some experiments, 30
min before STZ treatment, 3-aminobenzamide (3-ab; Sigma) prepared in 0.9%
saline was administered by intravenous injection at a dose of 340 mg/kg of body
weight. Control animals were similarly injected with vehicle only.
Determination of pancreatic insulin and glucose levels. Pancreata were dis-
sected; either they were placed entirely in 10 ml of acidified ethanol, or they were
divided longitudinally and one half was placed in acidified ethanol while the
other was prepared for histological examination. For insulin extraction, the organ
was cut into small pieces and then sonicated twice for 30 s at 216 mm (peak-to-
peak amplitude; Heat Systems). The sonicated material was kept at 4°C for 16 h
to extract the insulin and then aliquoted for storage at 220°C. The insulin
concentration was measured by radioimmunoassay, using rat insulin as the stan-
dard as previously described (15). The blood glucose level was determined by
reflectance photometry (Glucotrend blood glucose meter; Boehringer Mann-
heim) in conjunction with oxidoreductase reaction strips (Glucotrend glucose
strips; Roche).
Histological examination of pancreata. Mice were sacrificed at 8, 12, 24, 48,
and 96 h after STZ treatment. At autopsy, the pancreata were fixed in 4%
paraformaldehyde in 0.1 M cacodylate buffer (pH 7.2), processed for paraffin
embedding, sectioned (3 mm), and stained with hematoxylin-eosin. The percent-
age of morphologically abnormal b cells was calculated by scoring 500 to 1,000
islet cells per animal and was used as an indication of b-cell death. Scoring b-cell
apoptosis using b-cell-specific stains was not appropriate since the cytoplasmic
and nuclear morphology was not good enough when these methods were used.
Since necrotic and apoptotic nuclei are smaller than normal nuclei, the morpho-
logical scoring can be regarded as only semiquantitative. Therefore, apoptosis
and necrosis was confirmed by transmission electron microscopy. Mice were
perfused with 4% paraformaldehyde in 0.1 M cacodylate buffer (pH 7.2), and 1-
by 3-mm slices of pancreas were transferred to 3% glutaraldehyde in 0.1 M
sodium cacodylate buffer (pH 7.2) for 3 h, resin embedded, and stained for
electron microscopy as previously described (20).
Immunohistochemistry. (i) Insulin. Formalin-fixed pancreata were embedded
in paraffin, and 3-mm-thick sections were cut and mounted onto 3-aminopropyl-
triethoxysilane-coated slides. After being dewaxed through xylene and absolute
ethanol, the slides were rehydrated through decreasing concentrations of ethanol
(100, 90, 70, and 40%) and rinsed in distilled water. The slides were washed
thoroughly in Tris-buffered saline (pH 7.5) (TBS), and endogenous peroxidase
was blocked by incubation with 3% H2O2 in TBS for 20 min. The slides were
again washed in water and TBS and incubated with 5% normal rabbit serum for
20 min, before being exposed to the primary antibody, a polyclonal guinea pig
anti-swine insulin (1:4 dilution; Dako) at 4°C overnight. After being washed in
TBS, the slides were incubated with the secondary antibody, biotinylated rabbit
anti-guinea pig immunoglobulins (1:200 dilution; Dako) for 30 min at room
temperature, washed in TBS, and incubated with an avidin-biotin-horseradish
peroxidase complex (Dako) for 40 min at room temperature. The antibody-
antigen complexes were visualized by 3,3-diaminobenzidine (Sigma) staining for
5 min. Finally, the slides were counterstained with hematoxylin, dehydrated, and
mounted.
(ii) T-cell markers CD4 and CD8. Pancreata were snap frozen in liquid
nitrogen, and 4- to 5-mm sections were prepared. The sections were then fixed in
cold acetone for 10 min, air dried, and washed in TBS. Endogenous peroxidase
was blocked as above. The sections were incubated with 5% normal rabbit serum
for 20 min and then exposed overnight to one of the primary antibodies, either
rat anti-mouse CD41, or rat anti-mouse CD81 (BD PharMingen), at 2 mg/ml.
After being washed in TBS, the sections were incubated with biotinylated rabbit
anti-rat immunoglobulins (1:300 dilution; Dako) for 30 min at room tempera-
ture. Treatment with avidin-biotin-horseradish peroxidase and then 3,3-diami-
nobenzidine was as used for the detection of insulin.
Isolation of pancreatic islets and treatment with STZ. Islets were isolated
using the method of Lake et al. (22). Using this method, 150 to 200 islets could
be reliably obtained. Groups of 150 freshly isolated islets (one animal) were
incubated for 30 min in 2.2 mM STZ in Ham’s F-10 medium (Life Technologies)
or in medium only.
Isolation of islet nuclei and estimation of PARP activity. PARP activity in
isolated islets was measured essentially as previously described (3). Briefly, fol-
lowing STZ treatment, the islets were washed in Ham’s F-10 medium and
resuspended in a solution containing 250 mM sucrose, 10 mM HEPES (pH 7.4),
2.5 mM EDTA, 2 mM cysteine, and 0.02% bovine serum albumin. The islets
were left on ice for 5 min to lyse and then dispersed by rapid pipetting. The nuclei
were pelleted by centrifugation at 1,000 3 g for 3 min and resuspended in 100 ml
of buffer (50 mM Tris-HCl [pH 7.5], 30% glycerol, 1 mM EDTA, 0.5 mM EGTA)
and added to an equal volume of 100 mM Tris-HCl (pH 8.0)–20 mM 2-mercap-
toethanol–10 mM MgCl2 containing 5 mCi of [2,5,8-3H]NAD (Amersham Phar-
macia Biotech). The mixture was vortexed briefly and incubated for 30 min at
37°C; then 1 ml of ice-cold stop solution (10% trichloroacetic acid, 2% sodium
pyrophosphate decahydrate) was added. The samples were left on ice for 45 min
and then centrifuged at 12,000 3 g for 10 min. The supernatant was aspirated,
and the pellet was washed three more times with 1 ml of stop solution and then
once in 0.6 M perchloric acid. The pellet resuspended and left overnight in 200
ml of 0.04 N NaOH. A portion (150 ml) of the solution was added to a scintillant,
and the amount of radioactivity present was measured in a scintillation counter.
The remainder of the solution was used to measure DNA content as previously
described (21). Results are expressed as femtomoles of NAD1 incorporated per
minute per microgram of DNA.
Statistical analysis. The results obtained with groups from each study were
first analyzed using analysis of variance. Groups that showed differences were
further analyzed by Student’s t test.
RESULTS
Effect of APNG deletion on b-cell survival following a single
high dose of STZ. To test our hypothesis that APNG-deleted
mice should be resistant to STZ-induced necrosis of pancreatic
b cells, normal mice (APNG1/1) and mice heterozygous
(APNG1/2) or homozygous (APNG2/2) for the APNG null
mutation were injected with a single dose of STZ (140 mg/kg)
and scored for islet cell morphology by light microscopy. Un-
der light microscopy, necrotic islet cells could be easily iden-
tified by their pycnotic nuclei and fragmented cytoplasm (Fig.
1A). For the three mouse strains, the difference in the number
of necrotic islet cells after treatment was striking (Fig. 2A). At
8 h after the STZ dose, 60% of the cells from normal mice
showed nuclear pycnosis whereas fewer than 5% of the cells
from APNG2/2 mice did so. In normal mice, the number of
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islet cells containing pycnotic nuclei was reduced to back-
ground levels over the next 2 days. No delayed increase in
nuclear pycnosis was observed in the islets from APNG2/2
mice (Fig. 2A). Interestingly, there was a gene dosage effect,
with islet cells from APNG1/2 mice exhibiting approximately
half the normal level of nuclear pycnosis at 8, 12, and 24 h
postdose, although this was statistically significant only for the
8- and 12-h values.
The primary mode of cell death for islet cells from STZ-
treated APNG1/1 mice was confirmed to be necrosis by trans-
mission electron microscopy (Fig. 1B). The necrotic b cells
displayed clumping of the chromatin with ill-defined edges and
karyolysis, while the mitochondria were swollen. At 24 h post-
dose, most of the b cells were dead, leaving an area of necrosis
at the center of the islets. In contrast, the islets of APNG2/2
mice at 8 h postdose contained only an occasional necrotic b
cell. However, in APNG2/2 mice and to a lesser extent in
APNG1/2 mice, significant numbers of apoptotic islet cells
were seen from 24 h, with a peak at 48 h postdose (Fig. 2B).
Under light microscopy, hematoxylin-and-eosin-stained apo-
ptotic b cells could be identified by their chromatin morphol-
ogy, size, and cytoplasmic staining (Fig. 1C). Apoptotic nuclei
were either clumped and marginated or fragmented into reg-
ularly shaped membrane-bound bodies. Apoptotic cells ap-
peared shrunken and more densely eosinophilic. Apoptosis
was confirmed by transmission electron microscopy; apoptotic
FIG. 1. Light and electron microscopy of sections of pancreatic islets at 8 and 48 h after the STZ dose (140 mg/kg). (A and B) Light microscopy
of islet cells from APNG1/1 mice reveals extensive necrosis with fragmented nuclei (arrow) at 8 h postdose (A), while electron microscopy shows
nuclei clumped with ill-defined edges (arrow) and karyolysis, indicative of necrosis (B). (C) In contrast, light microscopy of islets from APNG2/2
mice 48 h postdose showed increased numbers of apoptotic islet cells with shrunken cytoplasm and intact nuclear and cytoplasmic membranes.
Nuclei were clumped into well-defined masses marginated against the nuclear membrane (arrow). (D) Electron microscopy of the APNG2/2
STZ-treated islets showed cells with condensed nuclear bodies (arrow), intact membranes, and condensed cytoplasm containing insulin granules
(arrowhead), indicative of an apoptotic b cell. Magnification, 3400 (A and C); bar, 10 mm; 32,800 (B and D); bar, 2 mm.
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cells appeared shrunken but retained intact nuclear and cell
membranes (Fig. 1D). Nuclear chromatin was clumped into
well-defined masses marginated against the nuclear membrane
or in separate membrane-bound bodies. Apoptotic islet cells
stained positive for insulin, confirming that they were b cells
(data not shown).
Effect of APNG deletion on PARP activation. To confirm
that APNG deletion attenuated the activation of PARP,
thereby maintaining cellular ATP levels and preventing the
initial catastrophic necrosis, pancreatic islets were isolated
from APNG1/1 and APNG2/2 mice and treated with STZ in
vitro. Measurement of PARP activity made by the incorpora-
tion of [3H]NAD1 into poly(ADP-ribose) polymers showed
that APNG2/2 islets had significantly less PARP activity after
STZ treatment than did APNG1/1 islets (P , 0.01) and were
not significantly different from untreated controls (P 5 0.19)
(Fig. 3). Therefore, since DNA strand breaks are required for
PARP activation, this result indicates that the bulk of the
STZ-induced DNA base adducts were not repaired by base
excision in the absence of APNG. It is reasonable to suggest
that the persistence of at least a subset of these adducts could
be responsible for the apoptotic response observed in the
APNG2/2 mice.
Effect of APNG deletion on high-dose-STZ-induced diabe-
tes. The pancreatic insulin content was measured at 8 and 96 h
to give an indication of the extent of pancreatic b-cell destruc-
tion after a single high dose of STZ. Figure 4 shows that at 8 h,
pancreatic insulin levels in both APNG1/1 and APNG2/2
mice were similar. By 96 h, the pancreatic insulin content in
APNG1/1 mice had fallen by 90% to around 4 ng of insulin per
mg of pancreas whereas the levels in STZ-treated APNG2/2
mice were reduced by only 50% of the control level (Fig. 4).
These results corroborate the observed histological findings
and confirm that the insulin-secreting b cells are the apoptotic
cells of the APNG2/2 islets. Since previous reports had shown
that PARP-deficient mice were also resistant to STZ-induced
diabetes (2, 25, 33), we were interested in knowing the effect
of the PARP inhibitor 3-ab on diabetes induction in-the
APNG2/2 mice. Pretreatment of normal mice with 3-ab (340
FIG. 2. Proportion of islet cells showing nuclear pycnosis consistent
with necrosis (A) and islet cell apoptosis (B) in APNG1/1, APNG1/2,
and APNG2/2 mice 8 to 96 h after a single injection of STZ (140
mg/kg). Each data point represents the mean and standard error of the
mean for 500 islet cells from four animals.
FIG. 3. PARP activity in islets isolated from APNG1/1 and APNG2/2
mice. PARP activity was measured in islet cells following incubation
for 30 min in 2.2 mM STZ or medium alone. While PARP activity was
significantly increased in STZ-treated islets from APNG1/1 mice com-
pared to untreated controls (P , 0.001), there was no significant
difference in PARP activity between STZ-treated and control islets
from APNG2/2 mice. Error bars indicated the mean 6 standard de-
viation.
FIG. 4. Effect of pretreatment with 3-ab on pancreatic insulin lev-
els of APNG1/1 and APNG2/2 mice, 8 and 96 h after treatment with
a single dose of STZ (140 mg/kg). Error bars indicate the mean 6 the
standard error of the mean.
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mg/kg) substantially protected them against a fall in pancreatic
insulin levels at 96 h (Fig. 4), in agreement with the previous
reports. However, pretreatment with 3-ab had no effect on the
insulin levels of STZ-treated APNG2/2 mice at 96 h (Fig. 4).
Indeed, there was no significant difference between the pan-
creatic insulin levels in 3-ab-pretreated APNG1/1 and
APNG2/2 mice and APNG2/2 mice treated with STZ alone.
Since PARP acts at the DNA strand breaks arising from the
action of APNG and AP-endonuclease, these results indicate
that the APNG-deleted cells survive because of the absence of
DNA strand scission and that any inhibition of a later step in
the pathway has no effect on cell survival.
To further compare the mechanisms by which the lack of
APNG or PARP leads to cell survival in this system, we inves-
tigated the effect of 3-ab on islet cell morphology at 8 and 48
h after STZ treatment in APNG1/1 and APNG2/2 mice. As
expected, histological analysis at 8 h showed that 3-ab-pre-
treated APNG1/1 mice displayed considerably less b-cell ne-
crosis than did those treated with STZ alone (P , 0.001)
(Table 1). Similarly, PARP inhibition in APNG2/2 mice re-
sulted in a small but significant reduction in islet cell necrosis
(P , 0.05) (Table 1). This most probably reflects a low level of
strand break induction by nonenzymatic depurination and gly-
cosylase-catalyzed removal of STZ-induced oxidative base
damage to the DNA in the APNG2/2 mice. For apoptosis at
48 h, it is clear from Table 1 that 3-ab treatment of APNG1/1
mice did not produce a peak of apoptosis similar to that found
in APNG2/2 mice. The inhibition of PARP had no significant
effect on the peak of apoptosis observed in APNG2/2 islets
(P 5 0.15) (Table 1). These results suggest that it is the per-
sistence of DNA adducts that act as a signal for the cell to
undergo apoptosis.
Induction of diabetes in APNG2/2 mice after a single high
dose of STZ. To assess the long-term effects of high-dose STZ
treatment in APNG2/2 mice, STZ-treated animals were mon-
itored for general well-being over several months. At approx-
imately 8 months postdose, all the mice were diabetic, with
fasting blood glucose levels averaging above 10 mM and sig-
nificantly reduced pancreatic insulin levels compared to equiv-
alently aged untreated controls (Table 2). Several mice also
exhibited marked lipolysis, with greatly diminished fat pads.
Immumohistological examination of the pancreata showed a
marked decrease in islet insulin content and marked CD41
lymphocytic proliferation, but not CD81 proliferation, both
around and within the islets (Fig. 5), which was not seen in the
controls (data not shown). Although no similar study has been
reported for PARP-deficient mice, rodents pretreated with
3-ab developed b-cell specific insulomas 1 year after receiving
a single high dose of STZ (36, 40). Thus, the method of cell
death reported here, resulting from the persistence of DNA
adducts or the lack of DNA strand breaks, may have implica-
tions for the generation of secondary tumors following treat-
ment with chemotherapeutic alkylating agents.
Effect of APNG deletion on MLDS-induced b-cell apoptosis.
Since MLDS is a commonly used rodent model of type 1 dia-
betes, APNG1/1 and APNG2/2 mice were treated with STZ
(40 mg/kg) for 5 days, and 6 h after the last dose their pancre-
ata were dissected for histological examination. Pancreata
were also removed on day 11 to determine the effect of this
regimen on pancreatic insulin levels in these mouse strains. On
day 5, islets from both strains showed evidence of apoptosis,
with APNG2/2 mice showing a 2.5-fold increase in b-cell apo-
ptosis compared with their normal littermates (Table 3). By
day 11, however, this situation had been reversed (Table 3),
with less apoptosis being present in APNG2/2 mice. At this
later time, pancreatic insulin levels were approximately 30% of
control values in both mouse strains (data not shown), and this
was borne out by immunohistochemical staining for insulin,
which showed a decrease in staining intensity for both STZ-
treated APNG-deficient and normal mice (Fig. 6A to D). Islets
from both strains showed evidence of a low-grade CD41 and
CD81 lymphocytic infiltration at this time (Fig. 6E to J).
Therefore, under this STZ regimen, both mouse strains suc-
cumbed similarly to diabetes. However, evidence from the cell
morphology studies suggests that the initial signaling events
leading to apoptosis are different and occur more rapidly in the
absence of APNG.
DISCUSSION
This study demonstrates that APNG2/2 mice are essentially
resistant to the immediate cytotoxic effects of a single high
dose of STZ, analogous to that described for PARP-deficient
mice (2, 25, 33). However, significant differences in the extent
and timing of islet cell apoptosis were observed in both this and
the MLDS model of type 1 diabetes, suggesting that at least a
subset of the unrepaired DNA adducts can act as signals for
apoptosis. The finding that both APNG2/2 and PARP-defi-
cient mice are resistant to single-high-STZ-dose-induced b-cell
necrosis provides further evidence that the necrosis is caused
by DNA adduct removal, the subsequent induction of DNA
strand breaks by AP-endonuclease, and the activation of PARP.
This is also supported by our observation that in contrast to
APNG1/1 islets, APNG2/2 islets treated in vitro do not show
significant PARP activation. Since APNG2/2 and APNG1/1
mice have the same basal levels of PARP activity, the finding
TABLE 1. Effect of 3-ab on high-dose-STZ-induced b-cell
necrosis at 8 h and apoptosis at 48 h.
Mouse strain 3-ab % Necrosis at 8 h
a
(no. of mice)
% Apoptosis at 48 ha
(no. of mice)
APNG1/1 2 73 6 3.0 (5) 0.25 6 0.16 (4)
1 0.5 6 0.3 (5) 0.87 6 0.26 (4)
APNG2/2 2 2.1 6 0.7 (5) 4.3 6 1.0 (4)
1 0.2 6 0.1 (5) 2.63 6 0.56 (5)
a For apoptosis values, P , 0.01 for both comparisons between APNG1/1 and
APNG2/2 mice. For necrosis and apoptosis values, data are expressed as the
mean 6 the standard error of the mean.
TABLE 2. Long-term effects of a single high dose of STZ on blood
glucose and pancreatic insulin levels in APNG2/2 mice
Treatment Blood glucose level (mM)
a
(no. of mice)
Pancreatic insulin level
(ng/mg)a (no. of mice)
None (controls) 5.48 6 0.89 (7) 82.3 6 28 (6)
STZ (140 mg/kg) 13.1 6 3.3 (11)b 7.97 6 5.19 (7)
a P , 0.001 for comparisons between controls and STZ-treated mice. Values
are expressed as the mean 6 standard devation.
b Values do not include one animal, where the glucose level was .44 mM.
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that APNG2/2 mice lack a significant STZ-induced activation
of PARP indicates that the majority of STZ-induced DNA
strand breaks are due to the action of APNG on DNA adducts
that are substrates for this enzyme.
The presence of significant amounts of STZ-induced b-cell
apoptosis in APNG2/2 mice is a novel finding and supports
previous reports that PARP inhibitors protect cultured b cells
against STZ-induced necrosis but not against cytokine-induced
apoptosis (16, 18). To our knowledge, this is the first in vivo
evidence of increased apoptosis resulting from a reduced re-
pair of DNA adducts and supports a previous report of the
induction of apoptosis in cell lines lacking APNG treated in
vitro with MeOSO2(CH2)2-lexitropsin, which almost exclu-
sively forms 3-meA adducts (10). 3-meA is known to block
DNA replication by inhibiting the action of DNA polymerases
(23), and thus it is likely that stalled replication-transcription
forks at 3-meA adducts are the ultimate apoptotic signaling
lesions in STZ-treated APNG2/2 cells. Since 3-meA in DNA
has a half-life of only 24 h under physiological conditions in
vitro (24), its potential toxicity in cells undergoing replication
decreases with time, and this probably explains the timing of
the peak of apoptosis observed in islets from APNG2/2 mice
after STZ treatment. However, this could also be due in part to
FIG. 5. Immunohistochemical determination of autoimmune diabetes in APNG2/2 mice 8 months after treatment with STZ. (A and B)
Formalin-fixed sections from untreated (A) and STZ-treated (B) APNG2/2 mice were stained for insulin as described in Materials and Methods.
(C to F) CD41 and CD81 immunostaining was carried out on frozen sections. Hematoxylin-eosin (C) and insulin (D) staining indicate the position
of the islet in the section, while staining for the specific lymphocyte markers shows evidence of CD41 (E) but not CD81 (F) lymphocytic invasion
in the islet. The more porous nature of the frozen sections compared to the formalin-fixed sections made them unsuitable for quantitative
assessment of insulin content by this method. Arrows indicate the position of the islet in the section. Bar, 100 mm.
TABLE 3. Islet cell apoptosis following MLDS treatment
of APNG1/1 and APNG2/2 mice
Mouse strain Day % Apoptosis (no. of mice)a
APNG1/1 5 0.98 6 0.1b (5)
11 1.56 6 0.12c (11)
APNG2/2 5 2.42 6 0.21b (5)
11 1.03 6 0.18c (11)
a Values are expressed as the mean 6 the standard error of the mean.
b Day 5 values (P , 0.001).
c Day 11 values (P , 0.05).
5610 CARDINAL ET AL. MOL. CELL. BIOL.
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
cb.asm
.org/
D
ow
nloaded from
 
FIG. 6. Immunohistochemical determination of MLDS-induced autoimmune diabetes in APNG1/1 and APNG2/2 mice on day 11. (A to D)
Formalin-fixed pancreata stained for insulin. (E to J) Frozen sections of pancreata stained for CD41 (E, G, and I) or CD81 (F, H, and J). (A and
B) APNG1/1 control and MLDS, respectively; (C and D) APNG2/2 control and MLDS, respectively; (E and F) APNG1/1; (G and H) APNG2/2;
(I and J) control sections from untreated APNG2/2 mice. Bar, 50 mm.
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the formation of DNA strand breaks resulting from the spon-
taneous depurination of 3-meA over this period.
Evidence that 3-meA depurination was not the major apo-
ptotic signaling event was obtained from studies of islet cell
morphology following STZ treatment: 3-ab-pretreated APNG1/1
mice showed significantly less b-cell apoptosis than did APNG2/2
mice, consistent with the hypothesis that the unrepaired DNA
adducts, or a fraction thereof, act as the apoptotic signal. How-
ever, the degree of cell death, as measured by pancreatic in-
sulin levels, did not differ between APNG2/2 and PARP-in-
hibited APNG1/1 mice. Considering the kinetics of apoptotic
cell death over time, the degree of apoptosis seen in APNG2/2
mice would adequately explain the fall in pancreatic insulin
levels in these mice. Since the mode of STZ-induced b-cell
death in 3-ab-pretreated APNG1/1 mice is unclear, it is pos-
sible that there may be another mechanism of delayed b-cell
death. STZ is known to damage mitochondria, inhibiting ATP
production (7), and this would lead to loss of membrane in-
tegrity and necrosis. Necrosis by this mechanism, therefore,
may not involve nuclear DNA damage detectable as pycnotic
nuclei 8 h postdose and may be difficult to detect by light
microscopy, especially if it is a minor pathway.
Apoptosis is the mode of b-cell death in the NOD mouse
model (28). DNA adduct formation and APNG may also play
a role in the NOD mouse model and in immune-mediated
b-cell apoptosis. In addition to the N-methylpurines, which are
an integral part of methylation damage, APNG releases 1,N6-
ethenoadenine and deaminated adenine, both of which are
generated endogenously by a number of processes, including
macrophage-induced NO synthesis and lipid peroxidation
(9, 11, 26). Cytokine-generated reactive oxygen species
cause DNA strand breaks and b-cell apoptosis in vitro and
are thought to play a role in the induction of the immune-
mediated b-cell apoptosis seen in NOD mice (35). Thus, it is
possible that APNG may also protect against NO and some
immune-mediated apoptosis. Consistent with the idea that low
levels of APNG may contribute to susceptibility to autoimmu-
nity in NOD mice is the finding that NOD mice are very
sensitive to multiple low doses of STZ but relatively resistant to
a single high dose of STZ (32). The present study suggests that
strain differences in sensitivity to STZ could be explained by
differences in APNG activity and thus supports a recent article
reporting differences in DNA strand break induction and
PARP activation in two mouse strains (4).
The finding that APNG2/2 mice treated with a single high
dose of STZ develop a delayed lymphocytic proliferation and
diabetes contrasts with earlier reports on the induction of
b-cell tumors in rats given combined treatments of STZ and
PARP inhibitors (36, 40). These are important results since
they indicate that (i) inhibition of PARP may contribute to
carcinogenesis and (ii) the persistence of DNA adducts can
lead to an autoimmune reaction. It is possible that other ad-
ducts such as O6-methylguanine or DNA lesions induced by
oxidative damage are responsible for the tumors seen in PARP-
inhibited mice. Alternatively, the fidelity of DNA repair syn-
thesis may be compromised in PARP-inhibited b cells since
strand rejoining is known to occur more slowly in PARP-
treated cells (39). On the other hand, while the deletion of
APNG greatly reduces the ability of the cells to carry out base
excision repair of these adducts, perhaps crucially, the signal-
ing apparatus for other types of DNA damage, such as that
caused by reactive oxygen species, remains in place. Relevant
to this is the recent finding that PARP can promote inflam-
mation through its interaction with the redox-regulated tran-
scription factor NF-kB (31). In response to many agents, includ-
ing genotoxins and oxidative stress, this family of transcription
factors is involved both in the up-regulation of expression of
inducible nitric oxide synthase and several proinflammatory cy-
tokines and in the prevention of apoptosis initiation (13). In-
deed, the inappropriate expression of NF-kB and the resulting
autoimmune and inflammatory response has been proposed as
the critical event in the development of type 1 diabetes (17).
Thus, in APNG2/2 mice the biological consequence of an ac-
tive NF-kB signaling system is susceptibility to STZ-induced
autoimmune diabetes. We are currently assessing the biologi-
cal response of PARP2/2 and APNG-PARP double-null mice
in this system.
The lack of both b-cell apoptosis and any reported autoim-
munity in PARP-inhibited mice treated with a single high dose
of STZ suggests that b-cell apoptosis and not necrosis may be
necessary for the induction of the autoimmune reaction. These
findings are in keeping with recent studies by O’Brien et al.,
who showed that PARP-inhibited NOD mice are protected
from both b-cell apoptosis and the ensuing autoimmune reac-
tion (29). The observation that the immune reaction is CD4
positive suggests a role for antigen-presenting cells in the ac-
tivation of the immune system. It is possible, then, that the
difference between apoptotic and necrotic stimulation of the
immune system may lie in the extent to which antigen-present-
ing cells are activated after taking up the remains of the b cell.
In the MLDS model, the timing and extent of apoptosis in
APNG2/2 mice is consistent with a role for unrepaired 3-meA
adducts in this pathway. Although a proportion of the DNA
adducts can be removed in normal mice, daily treatment of
STZ would lead to an increase in the residual number of un-
repaired adducts. Thus, APNG2/2 mice may show more apo-
ptosis than APNG1/1 mice by virtue of their inability to re-
move STZ-induced DNA adducts. This is further supported by
the observation that APNG2/2 mice treated with a single high
dose of STZ also show b-cell apoptosis. For MLDS, the cu-
mulative effect of the STZ treatment resulted in the same
biological outcome, irrespective of APNG status. A major un-
resolved issue is why the autoimmune reaction is delayed 8
months after a single high dose of STZ in APNG2/2 mice but
occurs at day 11 in the MLDS model. One explanation may be
that a single high dose of STZ may not produce the same
T-lymphocyte imbalance that the MLDS regimen is thought to
produce. Additionally, as C57BL/6J mice age, they develop
immune dysregulation, again involving NF-kB signaling (34).
Thus, autoimmunity may require both apoptotic b-cell priming
of antigen-presenting cells and dysregulation of the lympho-
cyte subsets. Further studies are required to determine the
relationship between the persistence of DNA adducts, apopto-
sis, and the immune response.
In conclusion, this study has revealed three important find-
ings: (i) APNG deficiency leads to resistance to STZ-induced
necrosis, (ii) DNA adduct persistence can lead to cellular apo-
ptosis in vivo, and (iii) the inhibition of base excision repair
before the induction of DNA strand breaks can radically alter
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the biological outcome, preventing the onset of tumorigenesis
and promoting autoimmunity.
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